ContraFect Secures $20,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9569dfe0-4bd9-4189-9e60-e7ca9b251233 - Date
6/25/2015 - Company Name
ContraFect - Mailing Address
28 Wells Avenue 3rd Floor Yonkers, NY 10701 USA - Company Description
ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases. - Website
http://www.contrafect.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
